Reference is made to the stock exchange notice published by Marine Harvest ASA (the "Company") on 10 February 2017 regarding the conversion of EUR 6.3 million of the outstanding loan of the EUR 375 million convertible bond issued by Marine Harvest ASA with ISIN NO 001 0710395 into 661,254 new shares in the Company, each with a nominal value of NOK 7.50.
The share capital increase pertaining to the conversion has now been duly registered with the Norwegian Register of Business Enterprises. Following the registration of the share capital increase, the Company's total share capital is NOK 3,392,173,800, divided into 452,289,840 total shares, each with a nominal value of NOK 7.50.
This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.


BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S.
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 



